ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Review Article



Systematic Review on phytochemical and Pharmacological Aspects of Diospyros Melanoxylon Roxb

Dr.praveena Chinthala Praveena Chinthala,Fareeha Qureshi Fareeha Qureshi,Venkateswara Venkateswara Reddy Venkateswara Reddy.



Abstract
Download PDF Cited by 2 ArticlesPost

Phytoconstituents in Diospyros Melanoxylon Roxb is what gives it its therapeutic efficacy. Diospyros Melanoxylon Roxb has been used extensively for its medicinal qualities all over the world. Plant leaves may be bundled to create "beedi," a tobacco-filled product that has surpassed regular cigarettes in sales in India. Additional plant materials have been used for pharmacological testing, including the treatment of cancer. The use of organic solvents for the extraction of Diospyros Melanoxylon Roxb material and a different technique with a different solvent system for the clarification of pure chemicals is two important limitations. If the pentacyclic triterpenoid ursolic acid from D. melanoxylon and its molecular mechanisms are understood, there are several possibilities for the creation of better medicines for a range of diseases. The purpose of this work is to provide a thorough analysis of the chemical components, pharmacological activity, and traditional medicinal use of thyme D. melanoxylon. Antioxidant, anti-inflammatory, analgesic, antipyretic, anti-diabetic, antibacterial, anthelmintic, antihypertensive, cosmeceutical, and enzyme-inhibitory qualities are some of these biological actions.

Key words: Diospyros, anti-inflammatory, antioxidant, anti-diabetic, antibacterial







Bibliomed Article Statistics

34
36
55
33
22
16
21
16
10
R
E
A
D
S

21

25

150

37

92

59

29

51

25
D
O
W
N
L
O
A
D
S
040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.